Sp120
STOMACH
Date
May 6, 2023
Explore related products in the following collection:
Society: AGA
This session will have six talks on the indications, limitations, procedural and technical aspects on clinically useful GI physiology tests. The attendees will learn for which patients these test can be of value, and what type of results you can expect and how reliable these are. Furthermore, the attendees will receive information on how to interpret results from these tests.
This session will have six talks on the indications, limitations, procedural and technical aspects on clinically useful GI physiology tests. The attendees will learn for which patients these test can be of value, and what type of results you can expect and how reliable these are. Furthermore, the attendees will receive information on how to interpret results from these tests.
Presenter
Massachusetts General Hospital
Tracks
Related Products
UNDERSTANDING HOW NEW TECHNOLOGY GETS A NEW CPT CODE AND VALUATION
This session will provide attendees with the knowledge and skills to successfully create and implement new technology into their practices through negotiation with payors and securing support from hospital systems…
SMALL BOWEL POSTPRANDIAL RESPONSE IN FUNCTIONAL DYSPEPSIA COMPARED TO BLUNTED GASTROPARETICS AND HEALTHY SUBJECTS MEASURED BY WIRELESS MOTILITY CAPSULE
INTRODUCTION: Patients with upper gastrointestinal (UGI) symptoms of abdominal pain, nausea, vomiting, and bloating often complain within the postprandial period…
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
